Related Experiment Video
Updated: Jun 8, 2026

Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies
Published on: June 30, 2023
DLC1 negatively regulates angiogenesis in a paracrine fashion
Yi-Ping Shih1, Yi-Chun Liao, Yuan Lin
1Department of Biochemistry and Molecular Medicine, Center for Tissue Regeneration and Repair, University of California-Davis, Sacramento, California 95817, USA.
Abstract:
The Rho GTPase-activating protein DLC1 is a tumor suppressor that is often deleted in liver cancer and downregulated in other cancers. DLC1 regulates the actin cytoskeleton, cell shape, adhesion, migration, and proliferation through its Rho GTPase-activating protein activity and focal adhesion localization. In this study, we silenced DLC1 in nonmalignant prostate epithelial cells to explore its tumor suppression functions. Small hairpin RNA-mediated silencing of DLC1 was insufficient to promote more aggressive phenotypes associated with tumor cell growth. In contrast, DLC1 silencing promoted pro-angiogenic responses through vascular endothelial growth factor (VEGF) upregulation, accompanied by the accumulation of hypoxia-inducible factor 1α and its nuclear localization. Notably, modulation of VEGF expression by DLC1 was dependent on epidermal growth factor receptor-MAP/ERK kinase-hypoxia-inducible factor 1 signaling but on RhoA pathways. Clinically, VEGF upregulation is a highly significant event in prostate cancers in which DLC1 is downregulated. Thus, our results strongly suggest that loss of DLC1 may serve as a "second hit" in promoting angiogenesis in a paracrine fashion during tumorigenesis.
Insights
Loss of DLC1 tumor suppressor in prostate cells promotes angiogenesis via VEGF upregulation, not direct tumor growth. This suggests DLC1 loss acts as a "second hit" in cancer progression.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- The Rho GTPase-activating protein DLC1 functions as a tumor suppressor, frequently deleted in liver cancer and downregulated in other malignancies.
- DLC1 regulates critical cellular processes including the actin cytoskeleton, cell shape, adhesion, migration, and proliferation.
Purpose of the Study:
- To investigate the tumor suppressive functions of DLC1 by silencing it in nonmalignant prostate epithelial cells.
- To elucidate the molecular mechanisms underlying DLC1's role in prostate cancer development and progression.
Main Methods:
- Small hairpin RNA (shRNA) was used to silence DLC1 expression in prostate epithelial cells.
- Vascular Endothelial Growth Factor (VEGF) and Hypoxia-Inducible Factor 1α (HIF-1α) levels were assessed following DLC1 silencing.
- Signaling pathways involving Epidermal Growth Factor Receptor (EGFR), MAP/ERK kinase (MEK), and RhoA were analyzed.
Main Results:
- DLC1 silencing did not promote aggressive tumor cell growth phenotypes.
- DLC1 silencing led to increased pro-angiogenic responses, evidenced by Vascular Endothelial Growth Factor (VEGF) upregulation.
- VEGF upregulation was associated with increased accumulation and nuclear localization of Hypoxia-Inducible Factor 1α (HIF-1α).
- Modulation of VEGF by DLC1 involved EGFR-MAP/ERK kinase-HIF-1 signaling, independent of RhoA pathways.
Conclusions:
- Loss of DLC1 in prostate cells promotes angiogenesis through VEGF upregulation, potentially via EGFR-MAPK-HIF-1 signaling.
- Clinical data shows a significant correlation between VEGF upregulation and DLC1 downregulation in prostate cancers.
- The downregulation of DLC1 may act as a critical 'second hit' facilitating tumor angiogenesis in a paracrine manner during tumorigenesis.
More Related Videos
09:03Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
Published on: November 23, 2014
08:04In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
Published on: May 11, 2021
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Mechanism of Angiogenesis
Canonical Wnt Signaling Pathway
Paracrine Signaling
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...